Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation

Summary

Some studies have suggested that high levels of total white blood cell (WBC) count and C-reactive protein (CRP) may be considered as independent prognostic factors in patients with acute coronary syndromes (ACS) and/or after cardiac revascularisation by percutaneous coronary intervention or coronary artery bypass grafting surgery. Evidence on the role of neutrophils in cardiovascular disease is less compelling. Therefore, we conducted a systematic review of the literature with the aim of identifying all the available evidence to clarify the role of neutrophils (absolute or relative count, neutrophil/lymphocyte ratio) as a prognostic risk factor in patients with ACS and/or cardiac revascularisation. All published studies evaluating the role of neutrophils as a risk factor for clinical outcomes were assessed using the MEDLINE and EMBASE databases. Study selection, data extraction and validity assessment was performed independently by two reviewers. Twenty-one studies (17 of which had positive results) for a total of more than 34,000 patients were included. Ten of 13 studies in ACS patients found that neutrophils measured on-admission are related to mortality rate and/or to major adverse clinical events. A predictive value of neutrophils after cardiac revascularisation procedures was reported in seven out of eight studies. Most of the studies showed that neutrophils were independent predictors of cardiovascular outcomes when analysed concomitantly with other markers of inflammation (WBC, CRP). The findings of our systematic review highlight the potential application of this inexpensive and readily available inflammatory marker for risk stratification in patients with ACS and/or cardiac revascularisation.

Keywords

Systematic review - neutrophils - outcome - acute coronary syndromes - revascularisation

^* The first two authors contributed equally to this study.

• References

• 1 Libby P, Ridker PM, Hansson GK. Leducq Transatlantic Network on atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
• 2 Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?. Arterioscler Thromb Vasc Biol 2005; 25: 658-670.
• 3 Madjid M, Awan I, Willerson JT. et al. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004; 44: 1945-1956.
• 4 Ruggiero C, Metter EJ, Cherubini A. et al. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2007; 49: 1841-1850.
• 5 Buckley DI, Fu R, Freeman M. et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 483-495.
• 6 Palmerini T, Marzocchi A, Marrozzini C. et al. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation 2005; 112: 2332-2338.
• 7 Prasad A, Stone GW, Stuckey TD. et al. Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. Am J Cardiol 2007; 99: 1067-1071.
• 8 Palmerini T, Marzocchi A, Marrozzini C. et al. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardiothorac Surg 2007; 31: 685-690.
• 9 Wheeler JG, Mussolino ME, Gillum RF. et al. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004; 25: 1287-1292.
• 10 Avanzas P, Arroyo-Espliguero R, Cosín-Sales J. et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004; 90: 847-852.
• 11 Grau AJ, Boddy AW, Dukovic DA. et al CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004; 35: 1147-1152.
• 12 Chia S, Nagurney JT, Brown DF. et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2009; 103: 333-337.
• 13 Baetta R, Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives. Atherosclerosis 2010; 210: 1-13.
• 14 McGinn T, Wyer PC, Newman TB. et al For GG; Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004; 171: 1369-1373.
• 15 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. J Am Med Assoc 2000; 283: 2008-2012.
• 16 Higgins JP, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.
• 17 Ypil WM, Tria R, Abad SJG.. Absolute neutrophilia as predictor for the development of early-onset congestive heart failure in patients admitted for acute myocardial infarction. Phil Heart Center J 2002; 9: 2-7.
• 18 Dragu R, Huri S, Zuckerman R. et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 2008; 196: 405-412.
• 19 Rashidi F, Rashidi A, Golmohamadi A. et al. Does absolute neutrophilia predict early congestive heart failure after acute myocardial infarction? A cross-sectional study. South Med J 2008; 101: 19-23.
• 20 Järemo P, Nilsson O. Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction. Eur J Intern Med 2008; 19: 330-333.
• 21 O'Donoghue M, Morrow DA, Cannon CP. et al. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur Heart J 2008; 29: 984-991.
• 22 Núñez J, Núñez E, Bodí V. et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008; 101: 747-752.
• 23 Huang G, Zhong XN, Zhong B. et al. Significance of white blood cell count and its subtypes in patients with acute coronary syndrome. Eur J Clin Invest 2009; 39: 348-358.
• 24 Kyne L, Hausdorff JM, Knight E. et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000; 139: 94-100.
• 25 Tamhane UU, Aneja S, Montgomery D. et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; 102: 653-657.
• 26 Wong CK, French JK, Gao W. et al. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase. Am Heart J 2003; 145: 95-102.
• 27 Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol 2000; 86: 449-451.
• 28 Kirtane AJ, Bui A, Murphy SA. et al. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol 2004; 93: 532-536.
• 29 Gurm HS, Bhatt DL, Lincoff AM. et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003; 89: 1200-1204.
• 30 Duffy BK, Gurm HS, Rajagopal V. et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006; 97: 993-996.
• 31 Takahashi T, Hiasa Y, Ohara Y. et al. Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction. Circ J 2008; 72: 867-872.
• 32 Kruk M, Przyluski J, Kalinczuk L. et al ANIN Myocardial Infarction Registry Group. Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J 2008; 72: 205-211.
• 33 Khandaker MH, Lennon RJ, Simari RD. et al. Abstract 3747: Elevated Lymphocyte c ount prior to coronary stenting is the best predictor of long-term outcome among white blood cell subtypes. Circulation 2007; 116: II-852.
• 34 Newall N, Grayson AD, Oo AY. et al. Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1-year mortality after coronary artery bypass grafting. Ann Thorac Surg 2006; 81: 583-589.
• 35 Gibson PH, Croal BL, Cuthbertson BH. et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007; 154: 995-1002.
• 36 Arruda-Olson AM, Reeder GS, Bell MR. et al. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes 2009; 2: 656-662.
• 37 Hansen P. R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995; 91: 1872-1885.
• 38 De Servi S, Mazzone A, Ricevuti G. et al. Clinical and angiographic correlates of leukocyte activation in unstable angina. J Am Coll Cardiol 1995; 26: 1146-1150.
• 39 Biasucci LM, Liuzzo G, Giubilato S. et al. Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability. Eur Heart J 2009; 30: 2220-2225.
• 40 Narducci ML, Grasselli A, Biasucci LM. et al. High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol 2007; 50: 2369-2374.
• 41 Naruko T, Ueda M, Haze K. et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894-2900.
• 42 Manfredi AA, Rovere-Querini P, Maugeri N. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr Opin Hematol 2010; 17: 3-8.
• 43 Pluskota E, Woody NM, Szpak D. et al. Expression, activation, and function of integrin {alpha}M{beta}2 (Mac-1) on neutrophil-derived microparticles. Blood 2008; 112: 2327-2335.
• 44 Inoue T, Sakai Y, Hoshi K. et al. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998; 97: 2511-2518.
• 45 Welt FGP, Edelman ER, Simon DI. et al. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000; 20: 2553-2558.
• 46 Inoue T, Sata M, Hikichi Y. et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis. Circulation 2007; 115: 553-561.
• 47 Granfeldt A, Lefer DJ, Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res 2009; 83: 234-246.